JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥4,758 | ¥5,508 | ¥5,412 | ¥19,404 |
| Dep. & Amort. | ¥3,374 | ¥3,197 | ¥1,997 | ¥1,945 |
| Deferred Tax | ¥0 | ¥0 | -¥9,221 | -¥3,074 |
| Stock-Based Comp. | ¥0 | ¥71 | ¥173 | ¥177 |
| Change in WC | -¥328 | -¥6,055 | -¥2,956 | -¥9,030 |
| Other Non-Cash | -¥3,774 | ¥6,591 | -¥905 | -¥133 |
| Operating Cash Flow | -¥5,486 | ¥9,312 | -¥5,500 | ¥9,289 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥9,888 | -¥2,095 | -¥8,560 | -¥11,333 |
| Net Acquisitions | ¥145 | -¥600 | -¥6,717 | ¥8,167 |
| Inv. Purchases | ¥0 | ¥0 | -¥906 | -¥300 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥259 | ¥300 |
| Other Inv. Act. | -¥131 | ¥5 | ¥922 | -¥84 |
| Investing Cash Flow | -¥9,874 | -¥2,690 | -¥15,002 | -¥3,250 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥14,805 | ¥500 | ¥4,700 | -¥20 |
| Stock Issued | ¥21 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥2,530 | ¥15 | ¥10 | ¥10 |
| Dividends Paid | -¥2,505 | -¥2,500 | -¥2,739 | -¥2,169 |
| Other Fin. Act. | -¥55 | -¥46 | -¥23 | ¥0 |
| Financing Cash Flow | ¥9,736 | -¥2,031 | ¥1,948 | -¥2,179 |
| Forex Effect | ¥64 | ¥886 | ¥1,099 | ¥612 |
| Net Chg. in Cash | -¥5,560 | ¥5,478 | -¥17,455 | ¥4,473 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥18,756 | ¥13,278 | ¥30,733 | ¥26,260 |
| End Cash | ¥13,196 | ¥18,756 | ¥13,278 | ¥30,733 |
| Free Cash Flow | -¥15,374 | ¥7,217 | -¥14,060 | -¥2,044 |